Find clinical trials in your area

Search by disease and location to discover available clinical trials matching your criteria.

Matched clinical trials

  • Study of Venetoclax, Daratumumab, and Dexamethasone for Patients with Relapsed or Refractory Multiple Myeloma

    Not recruiting

    1 1 1
    Denmark France Germany
  • Study Comparing ABBV-383 with Standard Therapies for Adults with Relapsed or Refractory Multiple Myeloma

    Not recruiting

    1 1 1 1
    Austria Belgium Czechia Denmark France Germany +7
  • Study Comparing bb2121 with Standard Treatments for Patients with Relapsed and Refractory Multiple Myeloma

    Not recruiting

    1 1 1 1
    Belgium France Germany Italy The Netherlands Norway +1
  • Study on the Effectiveness and Safety of Cevostamab and Tocilizumab for Patients with Relapsed or Refractory Multiple Myeloma

    Not recruiting

    1 1 1
    Investigated drugs:
    Belgium France Germany Italy Spain
  • Study Comparing Daratumumab with Drug Combination for Young Patients with Newly Diagnosed Multiple Myeloma Eligible for Stem Cell Transplantation

    Not recruiting

    1 1 1
    Czechia Greece Italy
  • Study Comparing Talquetamab, Daratumumab, and Pomalidomide with Drug Combination for Patients with Relapsed or Refractory Multiple Myeloma

    Not recruiting

    1 1 1 1
    Investigated diseases:
    Belgium Czechia France Germany Greece Italy +3
  • Study on Mezigdomide, Carfilzomib, and Dexamethasone for Patients with Relapsed, Refractory, or Newly Diagnosed Multiple Myeloma

    Not recruiting

    1 1 1
    Denmark France Germany Greece Italy Spain
  • Study Comparing Belantamab Mafodotin with Pomalidomide and Dexamethasone to Bortezomib with Pomalidomide and Dexamethasone for Patients with Relapsed/Refractory Multiple Myeloma

    Not recruiting

    1 1 1 1
    Czechia France Germany Greece Italy Poland +1
  • Study on Atezolizumab and Drug Combinations for Advanced Malignancies in Patients from Previous Atezolizumab Trials

    Not recruiting

    1 1 1 1
    Belgium Czechia France Germany Greece Hungary +5
  • Study of iberdomide alone or with drug combinations for patients with multiple myeloma: testing safety and effectiveness of different doses

    Not recruiting

    1 1 1
    Investigated diseases:
    France Germany Italy The Netherlands Spain